Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610

References

• Kulik L, EL-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–491. doi:10.1053/j.gastro.2018.08.06530367835
   PubMed Web of Science ®Google Scholar
• Yeh MM, Yeung RS, Apisarnthanarax S, et al. Multidisciplinary perspective of hepatocellular carcinoma: a Pacific Northwest experience. World J Hepatol. 2015;7(11):1460–1483. doi:10.4254/wjh.v7.i11.146026085907
   PubMedGoogle Scholar
• Zoller H, Tilg H. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Metab Clin Exp. 2016;65(8):1151–1160. doi:10.1016/j.metabol.2016.01.01026907206
   PubMed Web of Science ®Google Scholar
• Alexander J, Torbenson M, Wu TT, Yeh MM. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study. J Gastroenterol Hepatol. 2013;28(5):848–854. doi:10.1111/jgh.1211623302015
   PubMed Web of Science ®Google Scholar
• Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol. 2014;20(30):10223–10237. doi:10.3748/wjg.v20.i30.1022325132740
   PubMed Web of Science ®Google Scholar
• Nakagawa S, Wei L, Song WM, et al. Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition. Cancer Cell. 2016;30(6):879–890. doi:10.1016/j.ccell.2016.11.00427960085
   PubMed Web of Science ®Google Scholar
• Bach DH, Lee SK, Sood AK. Circular RNAs in cancer. Mol Ther Nucleic Acids. 2019;16:118–129. doi:10.1016/j.omtn.2019.02.00530861414
   PubMedGoogle Scholar
• Mercer TR, Gerhardt DJ, Dinger ME, et al. Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat Biotechnol. 2011;30(1):99–104. doi:10.1038/nbt.202422081020
   PubMed Web of Science ®Google Scholar
• Panda AC, Grammatikakis I, Kim KM, et al. Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1. Nucleic Acids Res. 2017;45(7):4021–4035. doi:10.1093/nar/gkw120127928058
   PubMed Web of Science ®Google Scholar
• Zhao ZJ, Shen J. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol. 2017;14(5):514–521. doi:10.1080/15476286.2015.112216226649774
   PubMed Web of Science ®Google Scholar
• Yao Z, Xu R, Yuan L, et al. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death Dis. 2019;10(12):945. doi:10.1038/s41419-019-2176-y31822654
   PubMed Web of Science ®Google Scholar
• Tian F, Yu C, Wu M, Wu X, Wan L, Zhu X. MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis. Cell Prolif. 2019;52(5):e12635. doi:10.1111/cpr.1263531334580
   PubMed Web of Science ®Google Scholar
• Wang YG, Wang T, Ding M, Xiang SH, Shi M, Zhai B. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307. Cancer Lett. 2019;460:128–138. doi:10.1016/j.canlet.2019.06.00731207319
   PubMed Web of Science ®Google Scholar
• Liu BH, Zhang BB, Liu XQ, Zheng S, Dong KR, Dong R. Expression profiling identifies circular RNA signature in hepatoblastoma. Cell Physiol Biochem. 2018;45(2):706–719. doi:10.1159/00048716329414822
   PubMedGoogle Scholar
• Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64(5):311–336. doi:10.3322/caac.2124425104502
   PubMed Web of Science ®Google Scholar
• Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122–1143. doi:10.7150/thno.1154326199650
   PubMed Web of Science ®Google Scholar
• Adams BD, Kasinski AL, Slack FJ. Aberrant regulation and function of microRNAs in cancer. Curr Biol. 2014;24(16):R762–R776. doi:10.1016/j.cub.2014.06.04325137592
   PubMed Web of Science ®Google Scholar
• Zeng XC, Liu FQ, Yan R, et al. Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/beta-catenin signaling in human hepatocellular carcinoma. Mol Cancer. 2014;13:261. doi:10.1186/1476-4598-13-26125491321
   PubMed Web of Science ®Google Scholar
• Palanisamy V, Jakymiw A, Van Tubergen EA, D’Silva NJ, Kirkwood KL. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J Dent Res. 2012;91(7):651–658. doi:10.1177/002203451243737222302144
   PubMed Web of Science ®Google Scholar
• Wu J, Du X, Li W, et al. A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration. Apoptosis. 2017;22(6):852–864. doi:10.1007/s10495-017-1361-728315172
   PubMed Web of Science ®Google Scholar
• Gao G, Tian Z, Zhu HY, Ouyang XY. miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma. Cancer Cell Int. 2018;18:210. doi:10.1186/s12935-018-0696-730574019
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J, Li S, Zhou C, Qin Y, Li X. miR802 inhibits the aggressive behaviors of nonsmall cell lung cancer cells by directly targeting FGFR1. Int J Oncol. 2019;54(6):2211–2221. doi:10.3892/ijo.2019.476530942425
   PubMed Web of Science ®Google Scholar
• Blum HE. Molecular therapy and prevention of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2(1):11–22.14599923
   PubMedGoogle Scholar
• Villani R, Vendemiale G, Serviddio G. Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy. Int J Mol Sci. 2018;20(1):49. doi:10.3390/ijms20010049
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Veno MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• Liu L, Yang X, Li NF, Lin L, Luo H. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma. Cell Cycle. 2019;18(21):2939–2953. doi:10.1080/15384101.2019.166422331522588
   PubMed Web of Science ®Google Scholar
• Sun B, Gu X, Chen Z, Xiang J. MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth factor. Am J Cancer Res. 2015;5(12):3635–3644.26885452
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang J, Wu J, et al. MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein. Eur J Cancer. 2012;48(12):1904–1913. doi:10.1016/j.ejca.2011.11.02622189055
   PubMed Web of Science ®Google Scholar
• Yan Y, Peng Y, Ou Y, Jiang Y. MicroRNA-610 is downregulated in glioma cells, and inhibits proliferation and motility by directly targeting MDM2. Mol Med Rep. 2016;14(3):2657–2664. doi:10.3892/mmr.2016.555927485527
   PubMed Web of Science ®Google Scholar
• Wang L, Bo X, Zheng Q, Xiao X, Wu L, Li B. miR-296 inhibits proliferation and induces apoptosis by targeting FGFR1 in human hepatocellular carcinoma. FEBS Lett. 2016;590(23):4252–4262. doi:10.1002/1873-3468.1244227714806
   PubMed Web of Science ®Google Scholar
• Takano M, Shimada K, Fujii T, et al. Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis. BMC Cancer. 2016;16(1):903. doi:10.1186/s12885-016-2949-y27863477
   PubMedGoogle Scholar
• Matsuki M, Hoshi T, Yamamoto Y, et al. Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models. Cancer Med. 2018;7(6):2641–2653. doi:10.1002/cam4.151729733511
   PubMed Web of Science ®Google Scholar
• Hoshi T, Watanabe Miyano S, Watanabe H, et al. Lenvatinib induces death of human hepatocellular carcinoma cells harboring an activated FGF signaling pathway through inhibition of FGFR-MAPK cascades. Biochem Biophys Res Commun. 2019;513(1):1–7. doi:10.1016/j.bbrc.2019.02.01530944079
   PubMed Web of Science ®Google Scholar